<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">ETM-29-2-12792</article-id>
<article-id pub-id-type="doi">10.3892/etm.2024.12792</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Risk factors of acute kidney injury, septic shock and acute respiratory distress syndrome in patients with blood culture‑positive sepsis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>He</surname><given-names>Yujing</given-names></name>
<xref rid="af1-ETM-29-2-12792" ref-type="aff">1</xref>
<xref rid="fn1-ETM-29-2-12792" ref-type="author-notes">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zheng</surname><given-names>Caixia</given-names></name>
<xref rid="af2-ETM-29-2-12792" ref-type="aff">2</xref>
<xref rid="fn1-ETM-29-2-12792" ref-type="author-notes">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zeng</surname><given-names>Jianyong</given-names></name>
<xref rid="af2-ETM-29-2-12792" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Fu</surname><given-names>Yaojie</given-names></name>
<xref rid="af3-ETM-29-2-12792" ref-type="aff">3</xref>
<xref rid="c1-ETM-29-2-12792" ref-type="corresp"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ou</surname><given-names>Hongjie</given-names></name>
<xref rid="af2-ETM-29-2-12792" ref-type="aff">2</xref>
<xref rid="c1-ETM-29-2-12792" ref-type="corresp"/>
</contrib>
</contrib-group>
<aff id="af1-ETM-29-2-12792"><label>1</label>Intensive Care Unit, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, P.R. China</aff>
<aff id="af2-ETM-29-2-12792"><label>2</label>Department of Infectious Diseases, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, P.R. China</aff>
<aff id="af3-ETM-29-2-12792"><label>3</label>Emergency Department, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, P.R. China</aff>
<author-notes>
<corresp id="c1-ETM-29-2-12792"><italic>Correspondence to:</italic> Dr Hongjie Ou, Department of Infectious Diseases, The First Affiliated Hospital of Xiamen University, 10 Shanggu Road, Xiamen, Fujian 361000, P.R. China <email>ouhongjie@sina.com vu1can@sina.com </email></corresp>
<fn><p>Dr Yaojie Fu, Emergency Department, The First Affiliated Hospital of Xiamen University, 10 Shanggu Road, Xiamen, Fujian 361000, P.R. China <email>vu1can@sina.com</email></p></fn>
<fn id="fn1-ETM-29-2-12792"><p><sup>&#x002A;</sup>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="collection">
<month>02</month>
<year>2025</year></pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>12</month>
<year>2024</year></pub-date>
<volume>29</volume>
<issue>2</issue>
<elocation-id>42</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>09</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2025 He et al.</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Sepsis, a condition characterized by a dysregulated host response to infection, can progress to septic shock and lead to various complications. The present study aimed to identify risk factors for the early clinical identification of sepsis patients at heightened risk of complications. In the present study, a total of 383 hospitalized patients with sepsis and positive blood cultures were enrolled. Demographic characteristics, laboratory findings at admission and treatment outcomes were collected and analyzed. Among the 383 sepsis patients, 165 were diagnosed with acute kidney injury (AKI). Patients with AKI exhibited significantly lower platelet counts, elevated procalcitonin levels and higher Sequential Organ Failure Assessment (SOFA) scores. Logistic regression analysis identified the SOFA score &#x005B;odds ratio (OR)=1.269, 95&#x0025; confidence interval (CI): 1.067-1.510, P=0.007) as an independent predictor of AKI. Furthermore, patients with septic shock had lower platelet counts and higher white blood cell counts at admission. Multivariable analysis revealed that age (OR=1.024, 95&#x0025; CI: 1.001-1.047, P=0.039), procalcitonin (OR=1.018, 95&#x0025; CI: 1.003-1.032, P=0.015), SOFA score (OR=1.465, 95&#x0025; CI: 1.248-1.719, P&#x003C;0.001) and Pitt bacteremia score (OR=1.437, 95&#x0025; CI: 1.204-1.716, P&#x003C;0.001) were independently associated with septic shock. In addition, sepsis patients with acute respiratory distress syndrome (ARDS) were observed to have lower platelet counts, higher body weight and elevated alanine aminotransferase levels. Multivariable analysis identified the SOFA score (OR=1.177, 95&#x0025; CI: 1.095-1.265, P&#x003C;0.001) and body weight (OR=1.030, 95&#x0025; CI: 1.007-1.054, P=0.010) as independent predictors of ARDS. The present study highlights the risk factors associated with AKI, ARDS and septic shock in sepsis patients with positive blood cultures. Early identification and close monitoring of these factors are crucial for improving outcomes in sepsis management.</p>
</abstract>
<kwd-group>
<kwd>sepsis</kwd>
<kwd>risk factors</kwd>
<kwd>septic shock</kwd>
<kwd>acute kidney injury</kwd>
<kwd>acute respiratory distress syndrome</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding:</bold> This study was supported by the Natural Science Foundation of Fujian Province (grant no. 2021J011365).</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Sepsis, a life-threatening syndrome resulting from a dysregulated host response to infections, can progress to septic shock and various complications. This poses a major global health challenge owing to the elevated morbidity and mortality rates of sepsis (<xref rid="b1-ETM-29-2-12792 b2-ETM-29-2-12792 b3-ETM-29-2-12792 b4-ETM-29-2-12792" ref-type="bibr">1-4</xref>). A retrospective analysis conducted in 2014 revealed that sepsis was implicated in 35&#x0025; of hospital deaths in the United States (<xref rid="b3-ETM-29-2-12792" ref-type="bibr">3</xref>). Globally, an estimated 48.9 million sepsis cases with 11.0 million sepsis-related deaths occurred in 2017, contributing to &#x007E;20&#x0025; of global mortality (<xref rid="b2-ETM-29-2-12792" ref-type="bibr">2</xref>). These data emphasize the critical need to analyze factors associated with poor prognosis in sepsis.</p>
<p>Patients with sepsis often experience complications, such as acute kidney injury (AKI), septic shock and acute respiratory distress syndrome (ARDS), leading to a worse prognosis compared with others (<xref rid="b5-ETM-29-2-12792 b6-ETM-29-2-12792 b7-ETM-29-2-12792" ref-type="bibr">5-7</xref>). In AKI, controversies surround the treatment because of an inadequate understanding of its pathophysiological mechanisms (<xref rid="b8-ETM-29-2-12792" ref-type="bibr">8</xref>,<xref rid="b9-ETM-29-2-12792" ref-type="bibr">9</xref>). Septic shock, a subtype of sepsis, is characterized by circulatory failure and abnormal cell metabolism, which significantly decreases the prognosis of patients with sepsis, posing a substantial economic burden (<xref rid="b10-ETM-29-2-12792" ref-type="bibr">10</xref>,<xref rid="b11-ETM-29-2-12792" ref-type="bibr">11</xref>). Early detection of septic shock is challenging but crucial for improving patient outcomes. ARDS is the most common and early complication of sepsis (<xref rid="b12-ETM-29-2-12792" ref-type="bibr">12</xref>). Identifying risk factors for these complications is urgently needed to facilitate early intervention and personalized treatment, thereby enhancing the clinical treatment success rate.</p>
<p>Several models are currently available to predict sepsis. The Early Warning Score (EWS) (<xref rid="b13-ETM-29-2-12792" ref-type="bibr">13</xref>), calculated from a patient&#x0027;s vital signs and mental status, is widely used to identify patients with acute deterioration. Additionally, the Quick Sequential Organ Failure Assessment (qSOFA) and the National Early Warning Score (NEWS) are commonly employed for sepsis identification and mortality prediction (<xref rid="b14-ETM-29-2-12792" ref-type="bibr">14</xref>). Notably, the National Health Service in England has adopted a NEWS score of &#x2265;5 to indicate possible sepsis (<xref rid="b15-ETM-29-2-12792" ref-type="bibr">15</xref>). Despite these advances, predictive markers and models of sepsis-related complications remain insufficient. For AKI, the Acute Disease Quality Initiative 23 Consensus Conference recommends combining damage and functional biomarkers to improve the sensitivity of AKI definitions (<xref rid="b16-ETM-29-2-12792" ref-type="bibr">16</xref>). Similarly, early detection of ARDS is crucial, as sepsis and ARDS are independently associated with higher incidence, mortality and prolonged hospital stays (<xref rid="b17-ETM-29-2-12792" ref-type="bibr">17</xref>,<xref rid="b18-ETM-29-2-12792" ref-type="bibr">18</xref>). Currently, no evidence or consensus exists on screening patients for ARDS (<xref rid="b19-ETM-29-2-12792" ref-type="bibr">19</xref>). Therefore, studying the risk factors of sepsis-related complications is essential.</p>
<p>However, to analyze the factors related to the prognosis of sepsis, it is necessary to distinguish between different types of sepsis because the factors influencing each type may vary. Based on blood culture results, sepsis can be categorized into culture-negative and culture-positive (<xref rid="b20-ETM-29-2-12792" ref-type="bibr">20</xref>). Various factors influence these culture results, including hospital laboratory conditions and host-specific factors. Notably, a negative culture may result from pathogens requiring fastidious conditions that are difficult to culture. Subtle differences between culture-negative and culture-positive sepsis have been reported, such as longer hospital stays and extended mechanical ventilation in patients with culture-positive sepsis (<xref rid="b21-ETM-29-2-12792" ref-type="bibr">21</xref>). To evaluate patient prognoses more accurately, the present study focused exclusively on patients with sepsis and positive blood cultures. This approach allowed it to narrow the research scope and thoroughly investigate sepsis management and outcomes.</p>
<p>Therefore, the present study focused on sepsis patients with positive blood cultures, investigating the relationship between their clinical and demographic characteristics and the occurrence of complications. The objective was to identify risk factors for the early clinical identification of sepsis patients at elevated risk of complications, thereby providing evidence-based insights to enhance the management of sepsis.</p>
</sec>
<sec sec-type="Materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Study population</title>
<p>The present retrospective observational study was approved by the Ethics Committee of The First Affiliated Hospital of Xiamen University (Fujian, China; approval no. 2022-037). Written informed consent was obtained from all patients upon admission. A total of 383 hospitalized patients with sepsis confirmed by positive blood cultures were enrolled from the Intensive Care Unit (The First Affiliated Hospital of Xiamen University, Fujian, China) between January 2015 and December 2022. The inclusion criteria for the present study were: i) a diagnosis of sepsis based on the International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (<xref rid="b22-ETM-29-2-12792" ref-type="bibr">22</xref>) and ii) positive blood culture results.</p>
<p>Exclusion criteria were: i) Presence of other serious underlying diseases or HIV positivity that could independently contribute to complications and ii) incomplete clinical data essential for the analysis. A total of 229 patients were excluded for not meeting the inclusion criteria and an additional 22 patients were excluded due to blood culture contamination. Thus, 383 patients were included in the final analysis, comprising 239 males and 144 females, with a median age of 64 years (range: 18-79 years). The three most commonly identified pathogens were <italic>Escherichia coli</italic>, <italic>Klebsiella pneumoniae</italic> and <italic>Staphylococcus aureus</italic>.</p>
</sec>
<sec>
<title>Diagnosis of complications</title>
<p>In the present study, the diagnosis of ARDS followed the 2012 Berlin definition (<xref rid="b23-ETM-29-2-12792" ref-type="bibr">23</xref>), which defines ARDS as a condition where PaO<sub>2</sub>/FiO<sub>2</sub> &#x2264; 300. Septic shock is diagnosed if, after fluid resuscitation, vasopressors are still necessary to maintain the mean arterial pressure at &#x2265;65 mmHg serum lactate level &#x003E;2 mmol/l. The diagnosis of AKI adhered to the KDIGO guidelines (<xref rid="b24-ETM-29-2-12792" ref-type="bibr">24</xref>), defined as an increase in serum creatinine (CRE) by &#x2265;26.5 &#x00B5;mol/l within 48 h, a &#x2265;1.5-fold increase in CRE compared to the baseline value within 7 days, or a urine output &#x003C;0.5 ml/(kg&#x00B7;h) for 6 h.</p>
</sec>
<sec>
<title>Laboratory test and biomarkers</title>
<p>Blood samples were promptly collected and analyzed using the Sysmex SE-9000 analyzer (Sysmex UK Ltd.) for Complete Blood Count and the Olympus AU5400 analyzer (Olympus Corporation) for biochemical examination. Demographic characteristics, laboratory results upon admission and treatment outcomes were retrieved from the electronic medical records system. All laboratory tests included in the analysis were conducted within the first 24 h of sepsis diagnosis to ensure relevance to early sepsis management and prognosis.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Continuous variables with normal distributions were expressed as mean &#x00B1; standard deviation and their means were compared using the independent samples t-test. For non-normally distributed continuous variables, such as procalcitonin and alanine transaminase levels, data were presented as medians with interquartile ranges (25th percentile, 75th percentile) and comparisons were performed using non-parametric tests. Categorical variables were reported as frequencies and percentages and comparisons were made using the &#x03C7;<sup>2</sup> test for variables such as sex, the proportion of patients with cardiovascular disease, type 2 diabetes mellitus and pathogens identified. For all enrolled patients, univariate and multivariate logistic regression analyses were conducted to determine independent risk factors. Variables with a P-value &#x003C;0.1 in the univariate analysis were included in the multivariate model for further evaluation. The results of logistic regression analyses were reported as odds ratios (OR) with their corresponding 95&#x0025; confidence intervals (CI). All statistical analyses were performed using SPSS software version 26.0 (IBM Corp.). P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="Results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Risk factors associated with AKI in blood culture-positive sepsis patients</title>
<p>A total of 383 sepsis patients with positive blood cultures were included in the present study. Patients with AKI demonstrated significantly elevated levels of C-reactive protein (CRP; 88.10&#x00B1;58.92 vs. 110.76&#x00B1;69.01; P=0.002), reduced platelet counts (PLT; 187.37&#x00B1;112.97 vs. 138.84&#x00B1;114.14, P&#x003C;0.001) and higher SOFA scores (6.31&#x00B1;3.57 vs. 9.79&#x00B1;4.06, P&#x003C;0.001), as shown in <xref rid="tI-ETM-29-2-12792" ref-type="table">Table I</xref>.</p>
<p>Logistic regression analysis was performed to identify independent risk factors for AKI (<xref rid="tII-ETM-29-2-12792" ref-type="table">Table II</xref>). While PLT, procalcitonin (PCT) and SOFA score were identified as potential risk factors, only the SOFA score (OR=1.269, 95&#x0025; CI: 1.067-1.510, P=0.007) emerged as an independent predictor of AKI in blood culture-positive sepsis patients.</p>
</sec>
<sec>
<title>Risk factors associated with septic shock in blood culture-positive sepsis patients</title>
<p>The present study next identified several factors associated with septic shock among the 383 blood culture-positive sepsis patients. Patients with septic shock exhibited significantly lower PLT (196.12&#x00B1;119.83 vs. 148.66&#x00B1;109.92; P&#x003C;0.001) and higher WBC on admission (12.42&#x00B1;6.04 vs. 14.49&#x00B1;9.89; P=0.011), as shown in <xref rid="tIII-ETM-29-2-12792" ref-type="table">Table III</xref>.</p>
<p>Further investigation into independent predictors of septic shock was conducted through logistic regression analysis (<xref rid="tIV-ETM-29-2-12792" ref-type="table">Table IV</xref>). The results demonstrated that age (OR=1.024, 95&#x0025; CI: 1.001-1.047, P=0.039), PCT (OR=1.018, 95&#x0025; CI: 1.003-1.032, P=0.015), SOFA score (OR=1.465, 95&#x0025; CI: 1.248-1.719, P&#x003C;0.001) and Pitt bacteremia score (PITT) score (OR=1.437, 95&#x0025; CI: 1.204-1.716, P&#x003C;0.001) were independently associated with septic shock.</p>
</sec>
<sec>
<title>Risk factors associated with ARDS in blood culture-positive sepsis patients</title>
<p>Patients with ARDS were observed to have significantly lower PLT (191.57&#x00B1;115.22 vs. 156.11&#x00B1;114.75, P=0.007), higher body weight (59.57&#x00B1;11.35 vs. 63.15&#x00B1;11.81, P=0.007) and elevated ALT levels, as shown in <xref rid="tV-ETM-29-2-12792" ref-type="table">Table V</xref>.</p>
<p>To identify independent predictors of ARDS, we performed multivariate logistic regression analysis (<xref rid="tVI-ETM-29-2-12792" ref-type="table">Table VI</xref>). The results highlighted the SOFA score (OR=1.177, 95&#x0025; CI: 1.095-1.265, P&#x003C;0.001) and body weight (OR=1.030, 95&#x0025; CI: 1.007-1.054, P=0.010) as robust independent risk factors for ARDS in blood culture-positive sepsis patients.</p>
</sec>
</sec>
</sec>
<sec sec-type="Discussion">
<title>Discussion</title>
<p>The present study identified key factors associated with complications in sepsis patients. For AKI, the SOFA score emerged as the independent predictor. Septic shock was independently associated with age, PCT level, PITT score and SOFA score. Similarly, for ARDS, independent factors included body weight and the SOFA score.</p>
<p>Culture-negative sepsis presents exceptional diagnostic challenges for clinicians and microbiologists, raising concerns about the accuracy and applicability of current sepsis definitions (<xref rid="b25-ETM-29-2-12792" ref-type="bibr">25</xref>). Blood cultures may be negative for various reasons, such as sepsis or septic shock caused by atypical or non-culturable pathogens. Previous studies have indicated some subtle differences between blood culture-positive and culture-negative sepsis (<xref rid="b26-ETM-29-2-12792" ref-type="bibr">26</xref>,<xref rid="b27-ETM-29-2-12792" ref-type="bibr">27</xref>). While previous study suggests no statistically significant difference between culture-positive and culture-negative patients in terms of all-cause mortality, the need for mechanical ventilation, or renal replacement therapy requirements, or ICU length of stay (<xref rid="b21-ETM-29-2-12792" ref-type="bibr">21</xref>). Another study observed longer hospital stays and extended mechanical ventilation in the culture-positive sepsis patients (<xref rid="b27-ETM-29-2-12792" ref-type="bibr">27</xref>). The present study specifically focused on septic patients with positive blood cultures. This decision allowed it to narrow its scope and delve deeper into understanding specific aspects of sepsis management and outcomes.</p>
<p>Few comparative studies have investigated AKI or ARDS in patients with sepsis and either positive or negative blood cultures. A meta-analysis of 47 studies examining sepsis-related AKI found that a positive blood culture was an independent risk factor for AKI in patients with sepsis (OR=1.6; 95&#x0025; CI: 1.35-1.89) (<xref rid="b28-ETM-29-2-12792" ref-type="bibr">28</xref>). Similarly, another study confirmed that patients with positive cultures were more likely to develop ARDS than those with negative cultures (44.9&#x0025; vs. 34.9&#x0025;; P=0.013) (<xref rid="b29-ETM-29-2-12792" ref-type="bibr">29</xref>). These findings suggest that complications are more common in patients with sepsis and positive blood cultures, highlighting the need for close, continuous monitoring.</p>
<p>AKI is a frequent complication in patients with sepsis, but its pathophysiological mechanisms are unclear. Funahashi <italic>et al</italic> (<xref rid="b30-ETM-29-2-12792" ref-type="bibr">30</xref>). found that leukocyte infiltration was widespread in the renal tissues of mice with sepsis. Notably, the present study also found reduced Ly6B+ monocyte infiltration after miR-146a plasmid treatment. Previous studies have also implied that obesity significantly raises the risk of chronic kidney disease (<xref rid="b31-ETM-29-2-12792" ref-type="bibr">31</xref>,<xref rid="b32-ETM-29-2-12792" ref-type="bibr">32</xref>). The contribution of adipose tissue to renal injury in obesity is gaining prominence; however, the molecular mechanisms underlying these two conditions remain incompletely understood. Within the context of obesity, alterations in lipotoxicity and the secretory profile of adipose tissue drive inflammation, oxidative stress and fibrosis in the kidney, resulting in impaired renal function (<xref rid="b33-ETM-29-2-12792" ref-type="bibr">33</xref>,<xref rid="b34-ETM-29-2-12792" ref-type="bibr">34</xref>). Several studies have underlined the importance of weight loss in enhancing kidney function markers (<xref rid="b35-ETM-29-2-12792 b36-ETM-29-2-12792 b37-ETM-29-2-12792" ref-type="bibr">35-37</xref>). Although the mechanisms underlying sepsis-associated AKI remain elusive, the inflammatory cascade characteristics of sepsis appear to play a crucial role in its pathogenesis (<xref rid="b38-ETM-29-2-12792" ref-type="bibr">38</xref>). Traditional theories primarily attribute this condition to tissue hypoperfusion, leading to renal ischemia and acute tubular necrosis. However, AKI in patients with mild infection and early sepsis without cardiac output impairment challenges this view (<xref rid="b39-ETM-29-2-12792" ref-type="bibr">39</xref>). The current understanding suggests that the mechanism is not solely hypoperfusion-dependent but involves multiple factors, including nephron inflammation, glomerular dysfunction due to ischemia-reperfusion injury, oxidative stress, tubular damage mediated by cytokines and chemokines and apoptosis in tubular and mesenchymal cells (<xref rid="b40-ETM-29-2-12792" ref-type="bibr">40</xref>). Hence, the key contributors to sepsis-associated AKI may include impaired renal microvascular oxygenation, dysregulated immune responses and cellular dysfunction. The present study found that patients with AKI had a higher body weight, although the P-value was only 0.055. Additionally, it was observed that patients with AKI had prolonged PT, lower PLT counts and elevated PCT and CRP levels. Thus, the specific mechanisms underlying these associations require further research and exploration.</p>
<p>The primary mechanisms underlying ARDS in sepsis involve leukocyte and platelet recruitment, endothelial injury and oxidative stress. In the present study, the PLT and ALT levels were associated with the development of ARDS. Platelets are sensitive to environmental changes and are critical in immune response activation (<xref rid="b41-ETM-29-2-12792" ref-type="bibr">41</xref>,<xref rid="b42-ETM-29-2-12792" ref-type="bibr">42</xref>). Activated platelets release substances that aid in pathogen elimination and immune system activation. The interaction between CD40L and immune cell CD40 plays a role in the activation, proliferation and differentiation of helper T cells (<xref rid="b43-ETM-29-2-12792" ref-type="bibr">43</xref>). In animal models, Zhang <italic>et al</italic> (<xref rid="b44-ETM-29-2-12792" ref-type="bibr">44</xref>). discovered that cold-inducible RNA-binding protein can impede ICAM-1-mediated platelet-endothelial-neutrophil interactions in lung tissue, enhancing animal survival time and reducing hypoxia. Furthermore, Yu <italic>et al</italic> (<xref rid="b45-ETM-29-2-12792" ref-type="bibr">45</xref>) observed that membranous vesicles and platelet particles released during platelet activation contribute to increased levels of TNF-&#x03B1; and IL-1&#x03B2; inflammatory factors in the alveoli. This triggers neutrophil infiltration in extravascular areas and results in acute lung injury. In sepsis, the release of numerous pro-inflammatory substances can lead to vascular endothelial dysfunction, increase pulmonary microvascular permeability and drive the development and progression of ARDS (<xref rid="b46-ETM-29-2-12792" ref-type="bibr">46</xref>). Lung injury triggers the recruitment of innate immune cells, such as neutrophils and monocytes, to the alveolar space, causing damage to the alveolar epithelium and endothelium (<xref rid="b47-ETM-29-2-12792" ref-type="bibr">47</xref>). This is because the host&#x0027;s immune response is not consistently hyperactive. In the later stages of the disease, owing to the immune system&#x0027;s negative feedback and exhaustion, a state of immune paralysis may develop (<xref rid="b48-ETM-29-2-12792" ref-type="bibr">48</xref>). A complex interplay among the signaling pathways, inflammatory cytokines, recruited immune cells, immune paralysis and the complement system may contribute to the cascade of inflammatory reactions underlying sepsis and the associated ARDS. However, in the multivariate analysis, only the SOFA score and weight were identified as independent factors associated with ARDS. This may be because the SOFA score includes PLT counts, which obscures the effect of PLTs on ARDS. The present study further underscored the crucial role of the SOFA score in the clinical management of sepsis.</p>
<p>The SOFA score also proved effective as an independent factor for septic shock, reinforcing its vital role in managing sepsis patients. In the present study, SOFA score was confirmed to be an independent relevant factor both in ARDS, AKI and septic shock. Covering six organ systems, the SOFA score provides a comprehensive assessment of organ functions, crucial for navigating the complex pathophysiology of sepsis (<xref rid="b49-ETM-29-2-12792 b50-ETM-29-2-12792 b51-ETM-29-2-12792" ref-type="bibr">49-51</xref>). High clinical SOFA scores demand special attention for disease progression and outcomes.</p>
<p>The present study analyzed clinical variables to identify independent factors associated with sepsis-related complications such as AKI, ARDS and septic shock. It also adopted the widely recognized SOFA score to assess organ dysfunction, providing a basis for predicting outcomes. The aim was to offer practical insights by highlighting specific risk factors that clinicians can prioritize in treatment decisions, thereby enhancing the prospects for personalized care and improved patient outcomes.</p>
<p>The present study had some limitations. First, it is a retrospective study and all patients were enrolled from a single center, inevitably introducing bias. Second, data were sourced from electronic medical records. Relying on this method for demographic and treatment data carries the risk of potential incompleteness or inaccuracies. To address this issue, a two-author cross-validation approach was implemented for data extraction. Moreover, owing to objective constraints, the present study did not include the time from blood culture testing to the reporting of positive blood culture results in the analysis. Third, because of the retrospective design of The present study, it was only able to continuously include all eligible cases to ensure robust observations and a comprehensive analysis. Therefore, a prospective multicenter study is needed. The time from admission to blood culture results should be included as a variable to evaluate the risk factors related to complications in patients with sepsis.</p>
<p>The present study identified key risk factors associated with sepsis-related complications in patients with positive blood cultures. The results revealed that the SOFA score was an independent factor of AKI. Additionally, age, PCT level and the PITT and SOFA scores were identified as independent predictors of septic shock. The SOFA score and weight were identified as independent risk factors for ARDS. These findings underline the importance of the early identification and monitoring of these risk factors in sepsis management to improve patient outcomes.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The data generated in the present study may be requested from the corresponding author.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>YH and HO designed the study. YH, CZ, YF and JZ analyzed and interpreted the data from patients with sepsis. YF and HO were major contributors in writing the manuscript. JZ and HO reviewed and edited the manuscript. YH and YF confirm the authenticity of all the raw data. All authors read and approved the final version of the manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The present retrospective study was approved by the Ethics Committee of The First Affiliated Hospital of Xiamen University (Fujian, China; approval no. 2022-037). Written informed consent was obtained from all patients upon admission.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-ETM-29-2-12792"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>JX</given-names></name><name><surname>Donnelly</surname><given-names>JP</given-names></name><name><surname>Griffin</surname><given-names>R</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Safford</surname><given-names>MM</given-names></name><name><surname>Wang</surname><given-names>HE</given-names></name></person-group><article-title>Defining sepsis mortality clusters in the United States</article-title><source>Crit Care Med</source><volume>44</volume><fpage>1380</fpage><lpage>1387</lpage><year>2016</year><pub-id pub-id-type="pmid">27105174</pub-id><pub-id pub-id-type="doi">10.1097/CCM.0000000000001665</pub-id></element-citation></ref>
<ref id="b2-ETM-29-2-12792"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudd</surname><given-names>KE</given-names></name><name><surname>Johnson</surname><given-names>SC</given-names></name><name><surname>Agesa</surname><given-names>KM</given-names></name><name><surname>Shackelford</surname><given-names>KA</given-names></name><name><surname>Tsoi</surname><given-names>D</given-names></name><name><surname>Kievlan</surname><given-names>DR</given-names></name><name><surname>Colombara</surname><given-names>DV</given-names></name><name><surname>Ikuta</surname><given-names>KS</given-names></name><name><surname>Kissoon</surname><given-names>N</given-names></name><name><surname>Finfer</surname><given-names>S</given-names></name><etal/></person-group><article-title>Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of disease study</article-title><source>Lancet</source><volume>395</volume><fpage>200</fpage><lpage>211</lpage><year>2020</year><pub-id pub-id-type="pmid">31954465</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(19)32989-7</pub-id></element-citation></ref>
<ref id="b3-ETM-29-2-12792"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>C</given-names></name><name><surname>Dantes</surname><given-names>R</given-names></name><name><surname>Epstein</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>DJ</given-names></name><name><surname>Seymour</surname><given-names>CW</given-names></name><name><surname>Iwashyna</surname><given-names>TJ</given-names></name><name><surname>Kadri</surname><given-names>SS</given-names></name><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>Danner</surname><given-names>RL</given-names></name><name><surname>Fiore</surname><given-names>AE</given-names></name><etal/></person-group><article-title>Incidence and trends of sepsis in US Hospitals using clinical vs claims data, 2009-2014</article-title><source>JAMA</source><volume>318</volume><fpage>1241</fpage><lpage>1249</lpage><year>2017</year><pub-id pub-id-type="pmid">28903154</pub-id><pub-id pub-id-type="doi">10.1001/jama.2017.13836</pub-id></element-citation></ref>
<ref id="b4-ETM-29-2-12792"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhart</surname><given-names>K</given-names></name><name><surname>Daniels</surname><given-names>R</given-names></name><name><surname>Kissoon</surname><given-names>N</given-names></name><name><surname>Machado</surname><given-names>FR</given-names></name><name><surname>Schachter</surname><given-names>RD</given-names></name><name><surname>Finfer</surname><given-names>S</given-names></name></person-group><article-title>Recognizing sepsis as a global health priority-A WHO resolution</article-title><source>New Engl J Med</source><volume>377</volume><fpage>414</fpage><lpage>417</lpage><year>2017</year><pub-id pub-id-type="pmid">28658587</pub-id><pub-id pub-id-type="doi">10.1056/NEJMp1707170</pub-id></element-citation></ref>
<ref id="b5-ETM-29-2-12792"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peerapornratana</surname><given-names>S</given-names></name><name><surname>Manrique-Caballero</surname><given-names>CL</given-names></name><name><surname>Gomez</surname><given-names>H</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name></person-group><article-title>Acute kidney injury from sepsis: Current concepts, epidemiology, pathophysiology, prevention and treatment</article-title><source>Kidney Int</source><volume>96</volume><fpage>1083</fpage><lpage>1099</lpage><year>2019</year><pub-id pub-id-type="pmid">31443997</pub-id><pub-id pub-id-type="doi">10.1016/j.kint.2019.05.026</pub-id></element-citation></ref>
<ref id="b6-ETM-29-2-12792"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name></person-group><article-title>Acute lung injury caused by sepsis: How does it happen?</article-title><source>Front Med (Lausanne)</source><volume>10</volume><issue>1289194</issue><year>2023</year><pub-id pub-id-type="pmid">38076268</pub-id><pub-id pub-id-type="doi">10.3389/fmed.2023.1289194</pub-id></element-citation></ref>
<ref id="b7-ETM-29-2-12792"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecconi</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>L</given-names></name><name><surname>Levy</surname><given-names>M</given-names></name><name><surname>Rhodes</surname><given-names>A</given-names></name></person-group><article-title>Sepsis and septic shock</article-title><source>Lancet</source><volume>392</volume><fpage>75</fpage><lpage>87</lpage><year>2018</year><pub-id pub-id-type="pmid">29937192</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(18)30696-2</pub-id></element-citation></ref>
<ref id="b8-ETM-29-2-12792"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manrique-Caballero</surname><given-names>CL</given-names></name><name><surname>Del Rio-Pertuz</surname><given-names>G</given-names></name><name><surname>Gomez</surname><given-names>H</given-names></name></person-group><article-title>Sepsis-associated acute kidney injury</article-title><source>Crit Care Clin</source><volume>37</volume><fpage>279</fpage><lpage>301</lpage><year>2021</year><pub-id pub-id-type="pmid">33752856</pub-id><pub-id pub-id-type="doi">10.1016/j.ccc.2020.11.010</pub-id></element-citation></ref>
<ref id="b9-ETM-29-2-12792"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YM</given-names></name><name><surname>Chou</surname><given-names>YT</given-names></name><name><surname>Kan</surname><given-names>WC</given-names></name><name><surname>Shiao</surname><given-names>CC</given-names></name></person-group><article-title>Sepsis and acute kidney injury: A review focusing on the bidirectional interplay</article-title><source>Int J Mol Sci</source><volume>23</volume><issue>9159</issue><year>2022</year><pub-id pub-id-type="pmid">36012420</pub-id><pub-id pub-id-type="doi">10.3390/ijms23169159</pub-id></element-citation></ref>
<ref id="b10-ETM-29-2-12792"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name></person-group><article-title>Severe sepsis and septic shock</article-title><source>N Engl J Med</source><volume>369</volume><fpage>840</fpage><lpage>851</lpage><year>2013</year><pub-id pub-id-type="pmid">23984731</pub-id><pub-id pub-id-type="doi">10.1056/NEJMra1208623</pub-id></element-citation></ref>
<ref id="b11-ETM-29-2-12792"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>C</given-names></name><name><surname>Legrand</surname><given-names>M</given-names></name></person-group><article-title>Epidemiology of sepsis and septic shock</article-title><source>Curr Opin Anaesthesiol</source><volume>34</volume><fpage>71</fpage><lpage>76</lpage><year>2021</year><pub-id pub-id-type="pmid">33492864</pub-id><pub-id pub-id-type="doi">10.1097/ACO.0000000000000958</pub-id></element-citation></ref>
<ref id="b12-ETM-29-2-12792"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fein</surname><given-names>AM</given-names></name><name><surname>Calalang-Colucci</surname><given-names>MG</given-names></name></person-group><article-title>Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock</article-title><source>Crit Care Clin</source><volume>16</volume><fpage>289</fpage><lpage>317</lpage><year>2000</year><pub-id pub-id-type="pmid">10768083</pub-id><pub-id pub-id-type="doi">10.1016/s0749-0704(05)70111-1</pub-id></element-citation></ref>
<ref id="b13-ETM-29-2-12792"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>B</given-names></name></person-group><article-title>The National early warning score: From concept to NHS implementation</article-title><source>Clin Med (Lond)</source><volume>22</volume><fpage>499</fpage><lpage>505</lpage><year>2022</year><pub-id pub-id-type="pmid">36427887</pub-id><pub-id pub-id-type="doi">10.7861/clinmed.2022-news-concept</pub-id></element-citation></ref>
<ref id="b14-ETM-29-2-12792"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunetti</surname><given-names>E</given-names></name><name><surname>Isaia</surname><given-names>G</given-names></name><name><surname>Rinaldi</surname><given-names>G</given-names></name><name><surname>Brambati</surname><given-names>T</given-names></name><name><surname>De Vito</surname><given-names>D</given-names></name><name><surname>Ronco</surname><given-names>G</given-names></name><name><surname>Bo</surname><given-names>M</given-names></name></person-group><article-title>Comparison of diagnostic accuracies of qSOFA, NEWS, and MEWS to identify sepsis in older inpatients with suspected infection</article-title><source>J Am Med Dir Assoc</source><volume>23</volume><fpage>865</fpage><lpage>871.e2</lpage><year>2022</year><pub-id pub-id-type="pmid">34619118</pub-id><pub-id pub-id-type="doi">10.1016/j.jamda.2021.09.005</pub-id></element-citation></ref>
<ref id="b15-ETM-29-2-12792"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname><given-names>WL</given-names></name><name><surname>Rusli</surname><given-names>KDB</given-names></name><name><surname>Aitken</surname><given-names>LM</given-names></name></person-group><article-title>Early warning scores for sepsis identification and prediction of in-hospital mortality in adults with sepsis: A systematic review and meta-analysis</article-title><source>J Clin Nurs</source><volume>33</volume><fpage>2005</fpage><lpage>2018</lpage><year>2024</year><pub-id pub-id-type="pmid">38379353</pub-id><pub-id pub-id-type="doi">10.1111/jocn.17061</pub-id></element-citation></ref>
<ref id="b16-ETM-29-2-12792"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostermann</surname><given-names>M</given-names></name><name><surname>Zarbock</surname><given-names>A</given-names></name><name><surname>Goldstein</surname><given-names>S</given-names></name><name><surname>Kashani</surname><given-names>K</given-names></name><name><surname>Macedo</surname><given-names>E</given-names></name><name><surname>Murugan</surname><given-names>R</given-names></name><name><surname>Bell</surname><given-names>M</given-names></name><name><surname>Forni</surname><given-names>L</given-names></name><name><surname>Guzzi</surname><given-names>L</given-names></name><name><surname>Joannidis</surname><given-names>M</given-names></name><etal/></person-group><article-title>Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: A consensus statement</article-title><source>JAMA Netw Open</source><volume>3</volume><issue>e2019209</issue><year>2020</year><pub-id pub-id-type="pmid">33021646</pub-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.19209</pub-id></element-citation></ref>
<ref id="b17-ETM-29-2-12792"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auriemma</surname><given-names>CL</given-names></name><name><surname>Zhuo</surname><given-names>H</given-names></name><name><surname>Delucchi</surname><given-names>K</given-names></name><name><surname>Deiss</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Jauregui</surname><given-names>A</given-names></name><name><surname>Ke</surname><given-names>S</given-names></name><name><surname>Vessel</surname><given-names>K</given-names></name><name><surname>Lippi</surname><given-names>M</given-names></name><name><surname>Seeley</surname><given-names>E</given-names></name><etal/></person-group><article-title>Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis</article-title><source>Intensive Care Med</source><volume>46</volume><fpage>1222</fpage><lpage>1231</lpage><year>2020</year><pub-id pub-id-type="pmid">32206845</pub-id><pub-id pub-id-type="doi">10.1007/s00134-020-06010-9</pub-id></element-citation></ref>
<ref id="b18-ETM-29-2-12792"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotts</surname><given-names>JE</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name></person-group><article-title>Sepsis: Pathophysiology and clinical management</article-title><source>BMJ</source><volume>353</volume><issue>i1585</issue><year>2016</year><pub-id pub-id-type="pmid">27217054</pub-id><pub-id pub-id-type="doi">10.1136/bmj.i1585</pub-id></element-citation></ref>
<ref id="b19-ETM-29-2-12792"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Miao</surname><given-names>H</given-names></name><name><surname>Maimaijuma</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>G</given-names></name></person-group><article-title>Early identification and diagnosis, pathophysiology, and treatment of sepsis-related acute lung injury: A narrative review</article-title><source>J Thorac Dis</source><volume>16</volume><fpage>5457</fpage><lpage>5476</lpage><year>2024</year><pub-id pub-id-type="pmid">39268131</pub-id><pub-id pub-id-type="doi">10.21037/jtd-24-1191</pub-id></element-citation></ref>
<ref id="b20-ETM-29-2-12792"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>J</given-names></name><name><surname>Kym</surname><given-names>D</given-names></name><name><surname>Hur</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>YS</given-names></name><name><surname>Chun</surname><given-names>W</given-names></name><name><surname>Yoon</surname><given-names>D</given-names></name></person-group><article-title>The clinical differentiation of blood culture-positive and -negative sepsis in burn patients: A retrospective cohort study</article-title><source>Burns Trauma</source><volume>11</volume><issue>tkad031</issue><year>2023</year><pub-id pub-id-type="pmid">38116468</pub-id><pub-id pub-id-type="doi">10.1093/burnst/tkad031</pub-id></element-citation></ref>
<ref id="b21-ETM-29-2-12792"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afzal</surname><given-names>MS</given-names></name><name><surname>Nandan Chennuri</surname><given-names>R</given-names></name><name><surname>Naveed</surname><given-names>H</given-names></name><name><surname>Raveena Bai</surname><given-names>B</given-names></name><name><surname>Hanif</surname><given-names>R</given-names></name><name><surname>Shahzad</surname><given-names>Z</given-names></name><name><surname>Umer</surname><given-names>M</given-names></name><name><surname>Saleem</surname><given-names>F</given-names></name></person-group><article-title>Comparison of clinical outcomes between culture-positive and culture-negative sepsis and septic shock patients: A meta-analysis</article-title><source>Cureus</source><volume>15</volume><issue>e35416</issue><year>2023</year><pub-id pub-id-type="pmid">36987463</pub-id><pub-id pub-id-type="doi">10.7759/cureus.35416</pub-id></element-citation></ref>
<ref id="b22-ETM-29-2-12792"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>M</given-names></name><name><surname>Deutschman</surname><given-names>CS</given-names></name><name><surname>Seymour</surname><given-names>CW</given-names></name><name><surname>Shankar-Hari</surname><given-names>M</given-names></name><name><surname>Annane</surname><given-names>D</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Bernard</surname><given-names>GR</given-names></name><name><surname>Chiche</surname><given-names>JD</given-names></name><name><surname>Coopersmith</surname><given-names>CM</given-names></name><etal/></person-group><article-title>The third international consensus definitions for sepsis and septic shock (Sepsis-3)</article-title><source>JAMA</source><volume>315</volume><fpage>801</fpage><lpage>810</lpage><year>2016</year><pub-id pub-id-type="pmid">26903338</pub-id><pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id></element-citation></ref>
<ref id="b23-ETM-29-2-12792"><label>23</label><element-citation publication-type="journal"><comment>ARDS Definition Task Force</comment><person-group person-group-type="author"><name><surname>Ranieri</surname><given-names>VM</given-names></name><name><surname>Rubenfeld</surname><given-names>GD</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><name><surname>Ferguson</surname><given-names>ND</given-names></name><name><surname>Caldwell</surname><given-names>E</given-names></name><name><surname>Fan</surname><given-names>E</given-names></name><name><surname>Camporota</surname><given-names>L</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name></person-group><article-title>Acute respiratory distress syndrome: The Berlin Definition</article-title><source>JAMA</source><volume>307</volume><fpage>2526</fpage><lpage>2533</lpage><year>2012</year><pub-id pub-id-type="pmid">22797452</pub-id><pub-id pub-id-type="doi">10.1001/jama.2012.5669</pub-id></element-citation></ref>
<ref id="b24-ETM-29-2-12792"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khwaja</surname><given-names>A</given-names></name></person-group><article-title>KDIGO clinical practice guidelines for acute kidney injury</article-title><source>Nephron Clin Pract</source><volume>120</volume><fpage>c179</fpage><lpage>c184</lpage><year>2012</year><pub-id pub-id-type="pmid">22890468</pub-id><pub-id pub-id-type="doi">10.1159/000339789</pub-id></element-citation></ref>
<ref id="b25-ETM-29-2-12792"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Prost</surname><given-names>N</given-names></name><name><surname>Razazi</surname><given-names>K</given-names></name><name><surname>Brun-Buisson</surname><given-names>C</given-names></name></person-group><article-title>Unrevealing culture-negative severe sepsis</article-title><source>Crit Care</source><volume>17</volume><issue>1001</issue><year>2013</year><pub-id pub-id-type="pmid">24074289</pub-id><pub-id pub-id-type="doi">10.1186/cc13022</pub-id></element-citation></ref>
<ref id="b26-ETM-29-2-12792"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangel-Frausto</surname><given-names>MS</given-names></name><name><surname>Pittet</surname><given-names>D</given-names></name><name><surname>Costigan</surname><given-names>M</given-names></name><name><surname>Hwang</surname><given-names>T</given-names></name><name><surname>Davis</surname><given-names>CS</given-names></name><name><surname>Wenzel</surname><given-names>RP</given-names></name></person-group><article-title>The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study</article-title><source>JAMA</source><volume>273</volume><fpage>117</fpage><lpage>123</lpage><year>1995</year><pub-id pub-id-type="pmid">7799491</pub-id></element-citation></ref>
<ref id="b27-ETM-29-2-12792"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name></person-group><article-title>Comparison of culture-negative and culture-positive sepsis or septic shock: A systematic review and meta-analysis</article-title><source>Crit Care</source><volume>25</volume><issue>167</issue><year>2021</year><pub-id pub-id-type="pmid">33964934</pub-id><pub-id pub-id-type="doi">10.1186/s13054-021-03592-8</pub-id></element-citation></ref>
<ref id="b28-ETM-29-2-12792"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Rates, predictors, and mortality of sepsis-associated acute kidney injury: A systematic review and meta-analysis</article-title><source>BMC Nephrol</source><volume>21</volume><issue>318</issue><year>2020</year><pub-id pub-id-type="pmid">32736541</pub-id><pub-id pub-id-type="doi">10.1186/s12882-020-01974-8</pub-id></element-citation></ref>
<ref id="b29-ETM-29-2-12792"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name></person-group><article-title>Comparison of clinical characteristics and outcomes between positive and negative blood culture septic patients: A retrospective cohort study</article-title><source>Infect Drug Resist</source><volume>14</volume><fpage>4191</fpage><lpage>4205</lpage><year>2021</year><pub-id pub-id-type="pmid">34675564</pub-id><pub-id pub-id-type="doi">10.2147/IDR.S334161</pub-id></element-citation></ref>
<ref id="b30-ETM-29-2-12792"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funahashi</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Masuda</surname><given-names>T</given-names></name><name><surname>Nishio</surname><given-names>F</given-names></name><name><surname>Kitai</surname><given-names>H</given-names></name><name><surname>Ishimoto</surname><given-names>T</given-names></name><name><surname>Kosugi</surname><given-names>T</given-names></name><name><surname>Tsuboi</surname><given-names>N</given-names></name><name><surname>Matsuda</surname><given-names>N</given-names></name><name><surname>Maruyama</surname><given-names>S</given-names></name><name><surname>Kadomatsu</surname><given-names>K</given-names></name></person-group><article-title>miR-146a targeted to splenic macrophages prevents sepsis-induced multiple organ injury</article-title><source>Lab Invest</source><volume>99</volume><fpage>1130</fpage><lpage>1142</lpage><year>2019</year><pub-id pub-id-type="pmid">30700845</pub-id><pub-id pub-id-type="doi">10.1038/s41374-019-0190-4</pub-id></element-citation></ref>
<ref id="b31-ETM-29-2-12792"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Dabbas</surname><given-names>W</given-names></name><name><surname>Gangemi</surname><given-names>A</given-names></name><name><surname>Benedetti</surname><given-names>E</given-names></name><name><surname>Lash</surname><given-names>J</given-names></name><name><surname>Finn</surname><given-names>PW</given-names></name><name><surname>Perkins</surname><given-names>DL</given-names></name></person-group><article-title>Obesity management and chronic kidney disease</article-title><source>Semin Nephrol</source><volume>41</volume><fpage>392</fpage><lpage>402</lpage><year>2021</year><pub-id pub-id-type="pmid">34715968</pub-id><pub-id pub-id-type="doi">10.1016/j.semnephrol.2021.06.010</pub-id></element-citation></ref>
<ref id="b32-ETM-29-2-12792"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Cui</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Gang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name></person-group><article-title>Obesity and chronic kidney disease</article-title><source>Am J Physiol Endocrinol Metab</source><volume>324</volume><fpage>E24</fpage><lpage>E41</lpage><year>2023</year><pub-id pub-id-type="pmid">36383637</pub-id><pub-id pub-id-type="doi">10.1152/ajpendo.00179.2022</pub-id></element-citation></ref>
<ref id="b33-ETM-29-2-12792"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escasany</surname><given-names>E</given-names></name><name><surname>Izquierdo-Lahuerta</surname><given-names>A</given-names></name><name><surname>Medina-Gomez</surname><given-names>G</given-names></name></person-group><article-title>Underlying mechanisms of renal lipotoxicity in obesity</article-title><source>Nephron</source><volume>143</volume><fpage>28</fpage><lpage>32</lpage><year>2019</year><pub-id pub-id-type="pmid">30625473</pub-id><pub-id pub-id-type="doi">10.1159/000494694</pub-id></element-citation></ref>
<ref id="b34-ETM-29-2-12792"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Taboada</surname><given-names>M</given-names></name><name><surname>Vila-Bedmar</surname><given-names>R</given-names></name><name><surname>Medina-Gomez</surname><given-names>G</given-names></name></person-group><article-title>From obesity to chronic kidney disease: How can adipose tissue affect renal function?</article-title><source>Nephron</source><volume>145</volume><fpage>609</fpage><lpage>613</lpage><year>2021</year><pub-id pub-id-type="pmid">33882488</pub-id><pub-id pub-id-type="doi">10.1159/000515418</pub-id></element-citation></ref>
<ref id="b35-ETM-29-2-12792"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz-Lopez</surname><given-names>A</given-names></name><name><surname>Becerra-Tomas</surname><given-names>N</given-names></name><name><surname>Ruiz</surname><given-names>V</given-names></name><name><surname>Toledo</surname><given-names>E</given-names></name><name><surname>Babio</surname><given-names>N</given-names></name><name><surname>Corella</surname><given-names>D</given-names></name><name><surname>Fit&#x00F3;</surname><given-names>M</given-names></name><name><surname>Romaguera</surname><given-names>D</given-names></name><name><surname>Vioque</surname><given-names>J</given-names></name><name><surname>Alonso-G&#x00F3;mez</surname><given-names>&#x00C1;M</given-names></name><etal/></person-group><article-title>Effect of an intensive weight-loss lifestyle intervention on kidney function: A randomized controlled trial</article-title><source>Am J Nephrol</source><volume>52</volume><fpage>45</fpage><lpage>58</lpage><year>2021</year><pub-id pub-id-type="pmid">33556935</pub-id><pub-id pub-id-type="doi">10.1159/000513664</pub-id></element-citation></ref>
<ref id="b36-ETM-29-2-12792"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spurny</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Sowah</surname><given-names>SA</given-names></name><name><surname>Nonnenmacher</surname><given-names>T</given-names></name><name><surname>Sch&#x00FC;bel</surname><given-names>R</given-names></name><name><surname>Kirsten</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>von Stackelberg</surname><given-names>O</given-names></name><name><surname>Ulrich</surname><given-names>CM</given-names></name><name><surname>Kaaks</surname><given-names>R</given-names></name><etal/></person-group><article-title>Changes in kidney fat upon dietary-induced weight loss</article-title><source>Nutrients</source><volume>14</volume><issue>1437</issue><year>2022</year><pub-id pub-id-type="pmid">35406052</pub-id><pub-id pub-id-type="doi">10.3390/nu14071437</pub-id></element-citation></ref>
<ref id="b37-ETM-29-2-12792"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolignano</surname><given-names>D</given-names></name><name><surname>Zoccali</surname><given-names>C</given-names></name></person-group><article-title>Effects of weight loss on renal function in obese CKD patients: A systematic review</article-title><source>Nephrol Dial Transplant 28 Suppl</source><volume>4</volume><fpage>v82</fpage><lpage>v98</lpage><year>2013</year><pub-id pub-id-type="pmid">24092846</pub-id><pub-id pub-id-type="doi">10.1093/ndt/gft302</pub-id></element-citation></ref>
<ref id="b38-ETM-29-2-12792"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrell</surname><given-names>ED</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name><name><surname>Pastor-Soler</surname><given-names>NM</given-names></name><name><surname>Hallows</surname><given-names>KR</given-names></name></person-group><article-title>Septic acute kidney injury: Molecular mechanisms and the importance of stratification and targeting therapy</article-title><source>Crit Care</source><volume>18</volume><issue>501</issue><year>2014</year><pub-id pub-id-type="pmid">25575158</pub-id><pub-id pub-id-type="doi">10.1186/s13054-014-0501-5</pub-id></element-citation></ref>
<ref id="b39-ETM-29-2-12792"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellepiane</surname><given-names>S</given-names></name><name><surname>Marengo</surname><given-names>M</given-names></name><name><surname>Cantaluppi</surname><given-names>V</given-names></name></person-group><article-title>Detrimental cross-talk between sepsis and acute kidney injury: New pathogenic mechanisms, early biomarkers and targeted therapies</article-title><source>Crit Care</source><volume>20</volume><issue>61</issue><year>2016</year><pub-id pub-id-type="pmid">26976392</pub-id><pub-id pub-id-type="doi">10.1186/s13054-016-1219-3</pub-id></element-citation></ref>
<ref id="b40-ETM-29-2-12792"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alobaidi</surname><given-names>R</given-names></name><name><surname>Basu</surname><given-names>RK</given-names></name><name><surname>Goldstein</surname><given-names>SL</given-names></name><name><surname>Bagshaw</surname><given-names>SM</given-names></name></person-group><article-title>Sepsis-associated acute kidney injury</article-title><source>Semin Nephrol</source><volume>35</volume><fpage>2</fpage><lpage>11</lpage><year>2015</year><pub-id pub-id-type="pmid">25795495</pub-id><pub-id pub-id-type="doi">10.1016/j.semnephrol.2015.01.002</pub-id></element-citation></ref>
<ref id="b41-ETM-29-2-12792"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauter</surname><given-names>RJ</given-names></name><name><surname>Sauter</surname><given-names>M</given-names></name><name><surname>Obrich</surname><given-names>M</given-names></name><name><surname>Emschermann</surname><given-names>FN</given-names></name><name><surname>Nording</surname><given-names>H</given-names></name><name><surname>Patzelt</surname><given-names>J</given-names></name><name><surname>Wendel</surname><given-names>HP</given-names></name><name><surname>Reil</surname><given-names>JC</given-names></name><name><surname>Edlich</surname><given-names>F</given-names></name><name><surname>Langer</surname><given-names>HF</given-names></name></person-group><article-title>Anaphylatoxin receptor C3aR contributes to platelet function, thrombus formation and in vivo haemostasis</article-title><source>Thromb Haemost</source><volume>119</volume><fpage>179</fpage><lpage>182</lpage><year>2019</year><pub-id pub-id-type="pmid">30597512</pub-id><pub-id pub-id-type="doi">10.1055/s-0038-1676349</pub-id></element-citation></ref>
<ref id="b42-ETM-29-2-12792"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>P</given-names></name><name><surname>Jindal</surname><given-names>NL</given-names></name><name><surname>Jagdis</surname><given-names>A</given-names></name><name><surname>Vadas</surname><given-names>P</given-names></name></person-group><article-title>Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis</article-title><source>J Allergy Clin Immunol</source><volume>135</volume><fpage>1424</fpage><lpage>1432</lpage><year>2015</year><pub-id pub-id-type="pmid">26051949</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2015.04.019</pub-id></element-citation></ref>
<ref id="b43-ETM-29-2-12792"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verschoor</surname><given-names>A</given-names></name><name><surname>Neuenhahn</surname><given-names>M</given-names></name><name><surname>Navarini</surname><given-names>AA</given-names></name><name><surname>Graef</surname><given-names>P</given-names></name><name><surname>Plaumann</surname><given-names>A</given-names></name><name><surname>Seidlmeier</surname><given-names>A</given-names></name><name><surname>Nieswandt</surname><given-names>B</given-names></name><name><surname>Massberg</surname><given-names>S</given-names></name><name><surname>Zinkernagel</surname><given-names>RM</given-names></name><name><surname>Hengartner</surname><given-names>H</given-names></name><name><surname>Busch</surname><given-names>DH</given-names></name></person-group><article-title>A platelet-mediated system for shuttling blood-borne bacteria to CD8&#x03B1;+ dendritic cells depends on glycoprotein GPIb and complement C3</article-title><source>Nat Immunol</source><volume>12</volume><fpage>1194</fpage><lpage>1201</lpage><year>2011</year><pub-id pub-id-type="pmid">22037602</pub-id><pub-id pub-id-type="doi">10.1038/ni.2140</pub-id></element-citation></ref>
<ref id="b44-ETM-29-2-12792"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Brenner</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>WL</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group><article-title>A cold-inducible RNA-binding protein (CIRP)-derived peptide attenuates inflammation and organ injury in septic mice</article-title><source>Sci Rep</source><volume>8</volume><issue>3052</issue><year>2018</year><pub-id pub-id-type="pmid">29434211</pub-id><pub-id pub-id-type="doi">10.1038/s41598-017-13139-z</pub-id></element-citation></ref>
<ref id="b45-ETM-29-2-12792"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Jing</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name></person-group><article-title>Simvastatin attenuates acute lung injury via regulating CDC42-PAK4 and endothelial microparticles</article-title><source>Shock</source><volume>47</volume><fpage>378</fpage><lpage>384</lpage><year>2017</year><pub-id pub-id-type="pmid">27513084</pub-id><pub-id pub-id-type="doi">10.1097/SHK.0000000000000723</pub-id></element-citation></ref>
<ref id="b46-ETM-29-2-12792"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharp</surname><given-names>C</given-names></name><name><surname>Millar</surname><given-names>AB</given-names></name><name><surname>Medford</surname><given-names>AR</given-names></name></person-group><article-title>Advances in understanding of the pathogenesis of acute respiratory distress syndrome</article-title><source>Respiration</source><volume>89</volume><fpage>420</fpage><lpage>434</lpage><year>2015</year><pub-id pub-id-type="pmid">25925331</pub-id><pub-id pub-id-type="doi">10.1159/000381102</pub-id></element-citation></ref>
<ref id="b47-ETM-29-2-12792"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Zemans</surname><given-names>RL</given-names></name><name><surname>Zimmerman</surname><given-names>GA</given-names></name><name><surname>Arabi</surname><given-names>YM</given-names></name><name><surname>Beitler</surname><given-names>JR</given-names></name><name><surname>Mercat</surname><given-names>A</given-names></name><name><surname>Herridge</surname><given-names>M</given-names></name><name><surname>Randolph</surname><given-names>AG</given-names></name><name><surname>Calfee</surname><given-names>CS</given-names></name></person-group><article-title>Acute respiratory distress syndrome</article-title><source>Nat Rev Dis Primers</source><volume>5</volume><issue>18</issue><year>2019</year><pub-id pub-id-type="pmid">30872586</pub-id><pub-id pub-id-type="doi">10.1038/s41572-019-0069-0</pub-id></element-citation></ref>
<ref id="b48-ETM-29-2-12792"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>RQ</given-names></name><name><surname>Ren</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>LY</given-names></name><name><surname>Xia</surname><given-names>ZF</given-names></name><name><surname>Yao</surname><given-names>YM</given-names></name></person-group><article-title>Advances in immune monitoring approaches for sepsis-induced immunosuppression</article-title><source>Front Immunol</source><volume>13</volume><issue>891024</issue><year>2022</year><pub-id pub-id-type="pmid">35619710</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.891024</pub-id></element-citation></ref>
<ref id="b49-ETM-29-2-12792"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Grooth</surname><given-names>HJ</given-names></name><name><surname>Geenen</surname><given-names>IL</given-names></name><name><surname>Girbes</surname><given-names>AR</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Parienti</surname><given-names>JJ</given-names></name><name><surname>Oudemans-van Straaten</surname><given-names>HM</given-names></name></person-group><article-title>SOFA and mortality endpoints in randomized controlled trials: A systematic review and meta-regression analysis</article-title><source>Crit Care</source><volume>21</volume><issue>38</issue><year>2017</year><pub-id pub-id-type="pmid">28231816</pub-id><pub-id pub-id-type="doi">10.1186/s13054-017-1609-1</pub-id></element-citation></ref>
<ref id="b50-ETM-29-2-12792"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambden</surname><given-names>S</given-names></name><name><surname>Laterre</surname><given-names>PF</given-names></name><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Francois</surname><given-names>B</given-names></name></person-group><article-title>The SOFA score-development, utility and challenges of accurate assessment in clinical trials</article-title><source>Crit Care</source><volume>23</volume><issue>374</issue><year>2019</year><pub-id pub-id-type="pmid">31775846</pub-id><pub-id pub-id-type="doi">10.1186/s13054-019-2663-7</pub-id></element-citation></ref>
<ref id="b51-ETM-29-2-12792"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Lei</surname><given-names>YP</given-names></name><name><surname>Zhou</surname><given-names>RX</given-names></name></person-group><article-title>SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: A systematic review and meta-analysis</article-title><source>Expert Rev Anti Infect Ther</source><volume>21</volume><fpage>891</fpage><lpage>900</lpage><year>2023</year><pub-id pub-id-type="pmid">37450490</pub-id><pub-id pub-id-type="doi">10.1080/14787210.2023.2237192</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<table-wrap id="tI-ETM-29-2-12792" position="float">
<label>Table I</label>
<caption><p>Demographics and clinical characteristics of All patient with or without AKI.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Characteristic</th>
<th align="center" valign="middle">Non-AKI group</th>
<th align="center" valign="middle">AKI group</th>
<th align="center" valign="middle">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Sample size</td>
<td align="center" valign="middle">218</td>
<td align="center" valign="middle">165</td>
<td align="center" valign="middle">-</td>
</tr>
<tr>
<td align="left" valign="middle">Sex, male (&#x0025;)</td>
<td align="center" valign="middle">129 (59.2)</td>
<td align="center" valign="middle">110 (66.7)</td>
<td align="center" valign="middle">0.134</td>
</tr>
<tr>
<td align="left" valign="middle">Age, years</td>
<td align="center" valign="middle">60.56&#x00B1;17.45</td>
<td align="center" valign="middle">63.2&#x00B1;16.72</td>
<td align="center" valign="middle">0.163</td>
</tr>
<tr>
<td align="left" valign="middle">Height, cm</td>
<td align="center" valign="middle">164.00&#x00B1;8.05</td>
<td align="center" valign="middle">165.32&#x00B1;7.19</td>
<td align="center" valign="middle">0.098</td>
</tr>
<tr>
<td align="left" valign="middle">Weight, kg</td>
<td align="center" valign="middle">61.12&#x00B1;11.90</td>
<td align="center" valign="middle">63.45&#x00B1;11.51</td>
<td align="center" valign="middle">0.055</td>
</tr>
<tr>
<td align="left" valign="middle">CVD, n (&#x0025;)</td>
<td align="center" valign="middle">76 (34.9)</td>
<td align="center" valign="middle">66 (40.0)</td>
<td align="center" valign="middle">0.303</td>
</tr>
<tr>
<td align="left" valign="middle">T2DM, n (&#x0025;)</td>
<td align="center" valign="middle">48 (22.0)</td>
<td align="center" valign="middle">38 (23.0)</td>
<td align="center" valign="middle">0.814</td>
</tr>
<tr>
<td align="left" valign="middle">WBC, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">13.37&#x00B1;8.57</td>
<td align="center" valign="middle">14.18&#x00B1;8.85</td>
<td align="center" valign="middle">0.367</td>
</tr>
<tr>
<td align="left" valign="middle">PLT, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">187.37&#x00B1;112.97</td>
<td align="center" valign="middle">138.84&#x00B1;114.14</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">CRP, mg/l</td>
<td align="center" valign="middle">88.10&#x00B1;58.92</td>
<td align="center" valign="middle">110.76&#x00B1;69.01</td>
<td align="center" valign="middle">0.002</td>
</tr>
<tr>
<td align="left" valign="middle">PCT, ng/ml</td>
<td align="center" valign="middle">2.60 (0.38, 17.13)</td>
<td align="center" valign="middle">15.54 (1.95, 76.16)</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">PT, sec</td>
<td align="center" valign="middle">15.08&#x00B1;3.17</td>
<td align="center" valign="middle">16.86&#x00B1;4.47</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">FIB, g/l</td>
<td align="center" valign="middle">4.34&#x00B1;1.89</td>
<td align="center" valign="middle">4.38&#x00B1;2.11</td>
<td align="center" valign="middle">0.858</td>
</tr>
<tr>
<td align="left" valign="middle">ALT, U/l</td>
<td align="center" valign="middle">16.00 (31.00, 75.75)</td>
<td align="center" valign="middle">36.00 (21.00, 82.50)</td>
<td align="center" valign="middle">0.094</td>
</tr>
<tr>
<td align="left" valign="middle">ALB, g/l</td>
<td align="center" valign="middle">30.13&#x00B1;5.82</td>
<td align="center" valign="middle">29.17&#x00B1;6.36</td>
<td align="center" valign="middle">0.138</td>
</tr>
<tr>
<td align="left" valign="middle">BUN, mmol/l</td>
<td align="center" valign="middle">8.47&#x00B1;4.29</td>
<td align="center" valign="middle">16.37&#x00B1;9.56</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">SOFA score</td>
<td align="center" valign="middle">6.31&#x00B1;3.57</td>
<td align="center" valign="middle">9.79&#x00B1;4.06</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">PITT</td>
<td align="center" valign="middle">3.26&#x00B1;2.83</td>
<td align="center" valign="middle">4.25&#x00B1;2.93</td>
<td align="center" valign="middle">0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Pathogens, n (&#x0025;)</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">0.554</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;<italic>E. coli</italic></td>
<td align="center" valign="middle">39 (17.9)</td>
<td align="center" valign="middle">39 (23.6)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;<italic>K. pneumoniae</italic></td>
<td align="center" valign="middle">39 (17.9)</td>
<td align="center" valign="middle">29 (17.6)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;<italic>S. aureus</italic></td>
<td align="center" valign="middle">24 (11.0)</td>
<td align="center" valign="middle">15 (9.1)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Others</td>
<td align="center" valign="middle">116 (53.2)</td>
<td align="center" valign="middle">82 (49.7)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>AKI, acute kidney injury; CVD, cardiovascular disease; T2DM, type 2 diabetes; WBC, white blood cells; PLT, platelets; CRP, C-reactive protein; PCT, procalcitonin; PT, prothrombin time; FIB, fibrinogen; ALT, alanine aminotransferase; ALB, albumin; BUN, blood urea nitrogen; SOFA, Sequential Organ Failure Assessment; PITT, Pitt bacteremia score.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-ETM-29-2-12792" position="float">
<label>Table II</label>
<caption><p>Univariate and multivariate analysis for AKI in sepsis patients.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">&#x00A0;</th>
<th align="center" valign="middle" colspan="3">Univariate analysis</th>
<th align="center" valign="middle" colspan="3">Multivariate analysis</th>
</tr>
<tr>
<th align="left" valign="middle">Variable</th>
<th align="center" valign="middle">OR</th>
<th align="center" valign="middle">95&#x0025; CI</th>
<th align="center" valign="middle">P-value</th>
<th align="center" valign="middle">OR</th>
<th align="center" valign="middle">95&#x0025; CI</th>
<th align="center" valign="middle">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Sex, male vs. female</td>
<td align="center" valign="middle">0.725</td>
<td align="center" valign="middle">0.475-1.105</td>
<td align="center" valign="middle">0.134</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">Age, years</td>
<td align="center" valign="middle">1.009</td>
<td align="center" valign="middle">0.997-1.021</td>
<td align="center" valign="middle">0.164</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">Height, cm</td>
<td align="center" valign="middle">1.023</td>
<td align="center" valign="middle">0.996-1.050</td>
<td align="center" valign="middle">0.099</td>
<td align="center" valign="middle">1.010</td>
<td align="center" valign="middle">0.957-1.065</td>
<td align="center" valign="middle">0.722</td>
</tr>
<tr>
<td align="left" valign="middle">Weight, kg</td>
<td align="center" valign="middle">1.017</td>
<td align="center" valign="middle">1.000-1.035</td>
<td align="center" valign="middle">0.056</td>
<td align="center" valign="middle">1.032</td>
<td align="center" valign="middle">0.999-1.066</td>
<td align="center" valign="middle">0.061</td>
</tr>
<tr>
<td align="left" valign="middle">CVD, yes vs. no</td>
<td align="center" valign="middle">1.246</td>
<td align="center" valign="middle">0.820-1.892</td>
<td align="center" valign="middle">0.303</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">T2DM, yes vs. no</td>
<td align="center" valign="middle">1.060</td>
<td align="center" valign="middle">0.653-1.719</td>
<td align="center" valign="middle">0.814</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">WBC, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">1.011</td>
<td align="center" valign="middle">0.988-1.035</td>
<td align="center" valign="middle">0.367</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">PLT, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">0.996</td>
<td align="center" valign="middle">0.994-0.998</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">0.999</td>
<td align="center" valign="middle">0.995-1.003</td>
<td align="center" valign="middle">0.638</td>
</tr>
<tr>
<td align="left" valign="middle">CRP, mg/l</td>
<td align="center" valign="middle">1.006</td>
<td align="center" valign="middle">1.002-1.009</td>
<td align="center" valign="middle">0.003</td>
<td align="center" valign="middle">0.995</td>
<td align="center" valign="middle">0.988-1.002</td>
<td align="center" valign="middle">0.189</td>
</tr>
<tr>
<td align="left" valign="middle">PCT, ng/ml</td>
<td align="center" valign="middle">1.020</td>
<td align="center" valign="middle">1.013-1.027</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">1.007</td>
<td align="center" valign="middle">0.992-1.023</td>
<td align="center" valign="middle">0.362</td>
</tr>
<tr>
<td align="left" valign="middle">PT, sec</td>
<td align="center" valign="middle">1.153</td>
<td align="center" valign="middle">1.078-1.234</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">0.937</td>
<td align="center" valign="middle">0.810-1.085</td>
<td align="center" valign="middle">0.384</td>
</tr>
<tr>
<td align="left" valign="middle">FIB, g/l</td>
<td align="center" valign="middle">1.010</td>
<td align="center" valign="middle">0.910-1.120</td>
<td align="center" valign="middle">0.858</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">ALT, U/l</td>
<td align="center" valign="middle">1.000</td>
<td align="center" valign="middle">0.999-1.001</td>
<td align="center" valign="middle">0.987</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">ALB, g/l</td>
<td align="center" valign="middle">0.974</td>
<td align="center" valign="middle">0.940-1.009</td>
<td align="center" valign="middle">0.139</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">BUN, mmol/l</td>
<td align="center" valign="middle">1.210</td>
<td align="center" valign="middle">1.154-1.268</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">1.059</td>
<td align="center" valign="middle">0.983-1.142</td>
<td align="center" valign="middle">0.133</td>
</tr>
<tr>
<td align="left" valign="middle">SOFA score</td>
<td align="center" valign="middle">1.263</td>
<td align="center" valign="middle">1.189-1.342</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">1.269</td>
<td align="center" valign="middle">1.067-1.510</td>
<td align="center" valign="middle">0.007</td>
</tr>
<tr>
<td align="left" valign="middle">PITT</td>
<td align="center" valign="middle">1.127</td>
<td align="center" valign="middle">1.049-1.211</td>
<td align="center" valign="middle">0.001</td>
<td align="center" valign="middle">0.949</td>
<td align="center" valign="middle">0.793-1.136</td>
<td align="center" valign="middle">0.570</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>AKI, acute kidney injury; OR, odds ratio; CI, confidence interval; CVD, cardiovascular disease; T2DM, type 2 diabetes; WBC, white blood cells; PLT, platelets; CRP, C-reactive protein; PCT, procalcitonin; PT, prothrombin time; FIB, fibrinogen; ALT, alanine aminotransferase; ALB, albumin; BUN, blood urea nitrogen; SOFA, Sequential Organ Failure Assessment; PITT, Pitt bacteremia score.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-ETM-29-2-12792" position="float">
<label>Table III</label>
<caption><p>Demographics and clinical data of all patient with or without septic shock.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Characteristic</th>
<th align="center" valign="middle">Non-septic shock group</th>
<th align="center" valign="middle">Septic shock group</th>
<th align="center" valign="middle">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Sample size</td>
<td align="center" valign="middle">144</td>
<td align="center" valign="middle">239</td>
<td align="center" valign="middle">-</td>
</tr>
<tr>
<td align="left" valign="middle">Sex, male (&#x0025;)</td>
<td align="center" valign="middle">80 (55.6)</td>
<td align="center" valign="middle">159 (66.5)</td>
<td align="center" valign="middle">0.032</td>
</tr>
<tr>
<td align="left" valign="middle">Age, year</td>
<td align="center" valign="middle">59.08&#x00B1;17.76</td>
<td align="center" valign="middle">63.15&#x00B1;16.64</td>
<td align="center" valign="middle">0.025</td>
</tr>
<tr>
<td align="left" valign="middle">Height, cm</td>
<td align="center" valign="middle">163.67&#x00B1;7.64</td>
<td align="center" valign="middle">165.10&#x00B1;7.71</td>
<td align="center" valign="middle">0.078</td>
</tr>
<tr>
<td align="left" valign="middle">Weight, kg</td>
<td align="center" valign="middle">62.61&#x00B1;11.76</td>
<td align="center" valign="middle">61.82&#x00B1;11.80</td>
<td align="center" valign="middle">0.525</td>
</tr>
<tr>
<td align="left" valign="middle">CVD, n (&#x0025;)</td>
<td align="center" valign="middle">53 (36.8)</td>
<td align="center" valign="middle">89 (37.2)</td>
<td align="center" valign="middle">0.932</td>
</tr>
<tr>
<td align="left" valign="middle">T2DM, n (&#x0025;)</td>
<td align="center" valign="middle">40 (27.8)</td>
<td align="center" valign="middle">46 (19.2)</td>
<td align="center" valign="middle">0.053</td>
</tr>
<tr>
<td align="left" valign="middle">WBC, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">12.42&#x00B1;6.04</td>
<td align="center" valign="middle">14.49&#x00B1;9.89</td>
<td align="center" valign="middle">0.011</td>
</tr>
<tr>
<td align="left" valign="middle">PLT, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">196.12&#x00B1;119.83</td>
<td align="center" valign="middle">148.66&#x00B1;109.92</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">CRP, mg/l</td>
<td align="center" valign="middle">87.91&#x00B1;64.39</td>
<td align="center" valign="middle">103.56&#x00B1;63.68</td>
<td align="center" valign="middle">0.041</td>
</tr>
<tr>
<td align="left" valign="middle">PCT, ng/ml</td>
<td align="center" valign="middle">1.36 (0.26, 14.42)</td>
<td align="center" valign="middle">9.19 (1.39, 51.85)</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">PT, sec</td>
<td align="center" valign="middle">15.03&#x00B1;3.34</td>
<td align="center" valign="middle">16.35&#x00B1;4.11</td>
<td align="center" valign="middle">0.001</td>
</tr>
<tr>
<td align="left" valign="middle">FIB, g/l</td>
<td align="center" valign="middle">4.67&#x00B1;1.89</td>
<td align="center" valign="middle">4.17&#x00B1;2.02</td>
<td align="center" valign="middle">0.018</td>
</tr>
<tr>
<td align="left" valign="middle">ALT, U/l</td>
<td align="center" valign="middle">30.50 (16.00, 60.00)</td>
<td align="center" valign="middle">35.50 (18.75, 88.50)</td>
<td align="center" valign="middle">0.055</td>
</tr>
<tr>
<td align="left" valign="middle">ALB, g/l</td>
<td align="center" valign="middle">30.57&#x00B1;6.15</td>
<td align="center" valign="middle">29.18&#x00B1;5.97</td>
<td align="center" valign="middle">0.035</td>
</tr>
<tr>
<td align="left" valign="middle">BUN, mmol/l</td>
<td align="center" valign="middle">10.63&#x00B1;8.59</td>
<td align="center" valign="middle">12.77&#x00B1;7.74</td>
<td align="center" valign="middle">0.014</td>
</tr>
<tr>
<td align="left" valign="middle">SOFA score</td>
<td align="center" valign="middle">4.67&#x00B1;2.61</td>
<td align="center" valign="middle">9.70&#x00B1;3.75</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">PITT,</td>
<td align="center" valign="middle">1.76&#x00B1;2.20</td>
<td align="center" valign="middle">4.85&#x00B1;2.67</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Pathogens, n (&#x0025;)</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">0.817</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;<italic>E. coli</italic></td>
<td align="center" valign="middle">26 (18.1)</td>
<td align="center" valign="middle">52 (21.8)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;<italic>K. pneumoniae</italic></td>
<td align="center" valign="middle">26 (18.1)</td>
<td align="center" valign="middle">42 (17.6)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;<italic>S. aureus</italic></td>
<td align="center" valign="middle">14 (9.7)</td>
<td align="center" valign="middle">25 (10.5)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Others</td>
<td align="center" valign="middle">78 (54.2)</td>
<td align="center" valign="middle">120 (50.2)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>CVD, cardiovascular disease; T2DM, type 2 diabetes; WBC, white blood cells; PLT, platelets; CRP, C-reactive protein; PCT, procalcitonin; PT, prothrombin time; FIB, fibrinogen; ALT, alanine aminotransferase; ALB, albumin; BUN, blood urea nitrogen; SOFA, Sequential Organ Failure Assessment; PITT, Pitt bacteremia score.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIV-ETM-29-2-12792" position="float">
<label>Table IV</label>
<caption><p>Univariate and multivariate analysis for septic shock in sepsis patients.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">&#x00A0;</th>
<th align="center" valign="middle" colspan="3">Univariate analysis</th>
<th align="center" valign="middle" colspan="3">Multivariate analysis</th>
</tr>
<tr>
<th align="left" valign="middle">Variable</th>
<th align="center" valign="middle">OR</th>
<th align="center" valign="middle">95&#x0025; CI</th>
<th align="center" valign="middle">P-value</th>
<th align="center" valign="middle">OR</th>
<th align="center" valign="middle">95&#x0025; CI</th>
<th align="center" valign="middle">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Sex, male vs. female</td>
<td align="center" valign="middle">0.629</td>
<td align="center" valign="middle">0.411-0.962</td>
<td align="center" valign="middle">0.032</td>
<td align="center" valign="middle">1.586</td>
<td align="center" valign="middle">0.511-4.920</td>
<td align="center" valign="middle">0.425</td>
</tr>
<tr>
<td align="left" valign="middle">Age, years</td>
<td align="center" valign="middle">1.014</td>
<td align="center" valign="middle">1.002-1.026</td>
<td align="center" valign="middle">0.025</td>
<td align="center" valign="middle">1.024</td>
<td align="center" valign="middle">1.001-1.047</td>
<td align="center" valign="middle">0.039</td>
</tr>
<tr>
<td align="left" valign="middle">Height, cm</td>
<td align="center" valign="middle">1.025</td>
<td align="center" valign="middle">0.997-1.053</td>
<td align="center" valign="middle">0.079</td>
<td align="center" valign="middle">1.031</td>
<td align="center" valign="middle">0.966-1.099</td>
<td align="center" valign="middle">0.359</td>
</tr>
<tr>
<td align="left" valign="middle">Weight, kg</td>
<td align="center" valign="middle">0.994</td>
<td align="center" valign="middle">0.977-1.012</td>
<td align="center" valign="middle">0.524</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">CVD, yes vs. no</td>
<td align="center" valign="middle">1.019</td>
<td align="center" valign="middle">0.664-1.563</td>
<td align="center" valign="middle">0.932</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">T2DM, yes vs. no</td>
<td align="center" valign="middle">0.620</td>
<td align="center" valign="middle">0.381-1.008</td>
<td align="center" valign="middle">0.054</td>
<td align="center" valign="middle">0.482</td>
<td align="center" valign="middle">0.196-1.183</td>
<td align="center" valign="middle">0.111</td>
</tr>
<tr>
<td align="left" valign="middle">WBC, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">1.031</td>
<td align="center" valign="middle">1.004-1.058</td>
<td align="center" valign="middle">0.025</td>
<td align="center" valign="middle">1.016</td>
<td align="center" valign="middle">0.967-1.068</td>
<td align="center" valign="middle">0.521</td>
</tr>
<tr>
<td align="left" valign="middle">PLT, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">0.996</td>
<td align="center" valign="middle">0.995-0.998</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">1.003</td>
<td align="center" valign="middle">1.000-1.007</td>
<td align="center" valign="middle">0.079</td>
</tr>
<tr>
<td align="left" valign="middle">CRP, mg/l</td>
<td align="center" valign="middle">1.004</td>
<td align="center" valign="middle">1.000-1.008</td>
<td align="center" valign="middle">0.042</td>
<td align="center" valign="middle">1.005</td>
<td align="center" valign="middle">0.998-1.012</td>
<td align="center" valign="middle">0.144</td>
</tr>
<tr>
<td align="left" valign="middle">PCT, ng/ml</td>
<td align="center" valign="middle">1.015</td>
<td align="center" valign="middle">1.008-1.023</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">1.018</td>
<td align="center" valign="middle">1.003-1.032</td>
<td align="center" valign="middle">0.015</td>
</tr>
<tr>
<td align="left" valign="middle">PT, sec</td>
<td align="center" valign="middle">1.117</td>
<td align="center" valign="middle">1.042-1.198</td>
<td align="center" valign="middle">0.002</td>
<td align="center" valign="middle">0.944</td>
<td align="center" valign="middle">0.823-1.083</td>
<td align="center" valign="middle">0.410</td>
</tr>
<tr>
<td align="left" valign="middle">FIB, g/l</td>
<td align="center" valign="middle">0.880</td>
<td align="center" valign="middle">0.791-0.979</td>
<td align="center" valign="middle">0.019</td>
<td align="center" valign="middle">0.847</td>
<td align="center" valign="middle">0.685-1.049</td>
<td align="center" valign="middle">0.128</td>
</tr>
<tr>
<td align="left" valign="middle">ALT, U/l</td>
<td align="center" valign="middle">1.001</td>
<td align="center" valign="middle">1.000-1.003</td>
<td align="center" valign="middle">0.108</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">ALB, g/l</td>
<td align="center" valign="middle">0.962</td>
<td align="center" valign="middle">0.928-0.998</td>
<td align="center" valign="middle">0.037</td>
<td align="center" valign="middle">0.971</td>
<td align="center" valign="middle">0.911-1.034</td>
<td align="center" valign="middle">0.358</td>
</tr>
<tr>
<td align="left" valign="middle">BUN, mmol/l</td>
<td align="center" valign="middle">1.036</td>
<td align="center" valign="middle">1.007-1.067</td>
<td align="center" valign="middle">0.016</td>
<td align="center" valign="middle">0.957</td>
<td align="center" valign="middle">0.913-1.002</td>
<td align="center" valign="middle">0.059</td>
</tr>
<tr>
<td align="left" valign="middle">SOFA score</td>
<td align="center" valign="middle">1.633</td>
<td align="center" valign="middle">1.474-1.808</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">1.465</td>
<td align="center" valign="middle">1.248-1.719</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">PITT</td>
<td align="center" valign="middle">1.700</td>
<td align="center" valign="middle">1.514-1.909</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">1.437</td>
<td align="center" valign="middle">1.204-1.716</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>OR, odds ratio; CI, confidence interval; CVD, cardiovascular disease; T2DM, type 2 diabetes; WBC, white blood cells; PLT, platelets; CRP, C-reactive protein; PCT, procalcitonin; PT, prothrombin time; FIB, fibrinogen; ALT, alanine aminotransferase; ALB, albumin; BUN, blood urea nitrogen; SOFA, Sequential Organ Failure Assessment; PITT, Pitt bacteremia score.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tV-ETM-29-2-12792" position="float">
<label>Table V</label>
<caption><p>Demographics and clinical data of all patient with or without ARDS.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Characteristic</th>
<th align="center" valign="middle">Non-ARDS group</th>
<th align="center" valign="middle">ARDS group</th>
<th align="center" valign="middle">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Sample size</td>
<td align="center" valign="middle">110</td>
<td align="center" valign="middle">273</td>
<td align="center" valign="middle">-</td>
</tr>
<tr>
<td align="left" valign="middle">Sex, male (&#x0025;)</td>
<td align="center" valign="middle">60 (54.5)</td>
<td align="center" valign="middle">179 (65.6)</td>
<td align="center" valign="middle">0.044</td>
</tr>
<tr>
<td align="left" valign="middle">Age, year</td>
<td align="center" valign="middle">62.34&#x00B1;19.22</td>
<td align="center" valign="middle">61.33&#x00B1;16.29</td>
<td align="center" valign="middle">0.604</td>
</tr>
<tr>
<td align="left" valign="middle">Height, cm</td>
<td align="center" valign="middle">163.54&#x00B1;7.97</td>
<td align="center" valign="middle">164.98&#x00B1;7.57</td>
<td align="center" valign="middle">0.097</td>
</tr>
<tr>
<td align="left" valign="middle">Weight, kg</td>
<td align="center" valign="middle">59.57&#x00B1;11.35</td>
<td align="center" valign="middle">63.15&#x00B1;11.81</td>
<td align="center" valign="middle">0.007</td>
</tr>
<tr>
<td align="left" valign="middle">CVD, n (&#x0025;)</td>
<td align="center" valign="middle">39 (35.5)</td>
<td align="center" valign="middle">103 (37.7)</td>
<td align="center" valign="middle">0.677</td>
</tr>
<tr>
<td align="left" valign="middle">T2DM, n (&#x0025;)</td>
<td align="center" valign="middle">29 (26.4)</td>
<td align="center" valign="middle">57 (20.9)</td>
<td align="center" valign="middle">0.244</td>
</tr>
<tr>
<td align="left" valign="middle">WBC, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">13.62&#x00B1;9.55</td>
<td align="center" valign="middle">13.75&#x00B1;8.34</td>
<td align="center" valign="middle">0.896</td>
</tr>
<tr>
<td align="left" valign="middle">PLT, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">191.57&#x00B1;115.22</td>
<td align="center" valign="middle">156.11&#x00B1;114.75</td>
<td align="center" valign="middle">0.007</td>
</tr>
<tr>
<td align="left" valign="middle">CRP, mg/l</td>
<td align="center" valign="middle">88.89&#x00B1;60.83</td>
<td align="center" valign="middle">101.33&#x00B1;65.43</td>
<td align="center" valign="middle">0.128</td>
</tr>
<tr>
<td align="left" valign="middle">PCT, ng/ml</td>
<td align="center" valign="middle">3.83 (0.64, 40.23)</td>
<td align="center" valign="middle">5.09 (0.60, 34.90)</td>
<td align="center" valign="middle">0.913</td>
</tr>
<tr>
<td align="left" valign="middle">PT, sec</td>
<td align="center" valign="middle">15.87&#x00B1;5.09</td>
<td align="center" valign="middle">15.85&#x00B1;3.32</td>
<td align="center" valign="middle">0.965</td>
</tr>
<tr>
<td align="left" valign="middle">FIB, g/l</td>
<td align="center" valign="middle">4.16&#x00B1;1.75</td>
<td align="center" valign="middle">4.44&#x00B1;2.06</td>
<td align="center" valign="middle">0.228</td>
</tr>
<tr>
<td align="left" valign="middle">ALT, U/l</td>
<td align="center" valign="middle">25.5 (14.25, 58.25)</td>
<td align="center" valign="middle">37.5 (20.25, 86.50)</td>
<td align="center" valign="middle">0.002</td>
</tr>
<tr>
<td align="left" valign="middle">ALB, g/l</td>
<td align="center" valign="middle">29.27&#x00B1;6.77</td>
<td align="center" valign="middle">29.87&#x00B1;5.80</td>
<td align="center" valign="middle">0.409</td>
</tr>
<tr>
<td align="left" valign="middle">BUN, mmol/l</td>
<td align="center" valign="middle">12.69&#x00B1;7.98</td>
<td align="center" valign="middle">11.68&#x00B1;8.18</td>
<td align="center" valign="middle">0.282</td>
</tr>
<tr>
<td align="left" valign="middle">SOFA score</td>
<td align="center" valign="middle">6.06&#x00B1;3.54</td>
<td align="center" valign="middle">8.51&#x00B1;4.19</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">PITT</td>
<td align="center" valign="middle">3.47&#x00B1;2.89</td>
<td align="center" valign="middle">3.77&#x00B1;2.93</td>
<td align="center" valign="middle">0.363</td>
</tr>
<tr>
<td align="left" valign="middle">Pathogens, n (&#x0025;)</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">0.691</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;<italic>E. coli</italic></td>
<td align="center" valign="middle">24 (21.8)</td>
<td align="center" valign="middle">54 (19.8)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;<italic>K. pneumoniae</italic></td>
<td align="center" valign="middle">16 (14.5)</td>
<td align="center" valign="middle">52 (19.0)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;<italic>S. aureus</italic></td>
<td align="center" valign="middle">13 (11.8)</td>
<td align="center" valign="middle">26 (9.5)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Others</td>
<td align="center" valign="middle">57 (51.8)</td>
<td align="center" valign="middle">141 (51.6)</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>ARDS, acute respiratory distress syndrome; CVD, cardiovascular disease; T2DM, type 2 diabetes; WBC, white blood cells; PLT, platelets; CRP, C-reactive protein; PCT, procalcitonin; PT, prothrombin time; FIB, fibrinogen; ALT, alanine aminotransferase; ALB, albumin; BUN, blood urea nitrogen; SOFA, Sequential Organ Failure Assessment; PITT, Pitt bacteremia score.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tVI-ETM-29-2-12792" position="float">
<label>Table VI</label>
<caption><p>Univariate and multivariate analysis for ARDS in sepsis patients.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">&#x00A0;</th>
<th align="center" valign="middle" colspan="3">Univariate analysis</th>
<th align="center" valign="middle" colspan="3">Multivariate analysis</th>
</tr>
<tr>
<th align="left" valign="middle">Variable</th>
<th align="center" valign="middle">95&#x0025; CI</th>
<th align="center" valign="middle">P-value</th>
<th align="center" valign="middle">95&#x0025; CI</th>
<th align="center" valign="middle">P-value</th>
<th align="center" valign="middle">95&#x0025; CI</th>
<th align="center" valign="middle">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Sex, male vs. female</td>
<td align="center" valign="middle">0.630</td>
<td align="center" valign="middle">0.402-0.989</td>
<td align="center" valign="middle">0.045</td>
<td align="center" valign="middle">0.842</td>
<td align="center" valign="middle">0.409-1.735</td>
<td align="center" valign="middle">0.642</td>
</tr>
<tr>
<td align="left" valign="middle">Age, years</td>
<td align="center" valign="middle">0.997</td>
<td align="center" valign="middle">0.984-1.010</td>
<td align="center" valign="middle">0.603</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">Height, cm</td>
<td align="center" valign="middle">1.025</td>
<td align="center" valign="middle">0.996-1.055</td>
<td align="center" valign="middle">0.098</td>
<td align="center" valign="middle">0.991</td>
<td align="center" valign="middle">0.945-1.039</td>
<td align="center" valign="middle">0.705</td>
</tr>
<tr>
<td align="left" valign="middle">Weight, kg</td>
<td align="center" valign="middle">1.027</td>
<td align="center" valign="middle">1.007-1.048</td>
<td align="center" valign="middle">0.008</td>
<td align="center" valign="middle">1.030</td>
<td align="center" valign="middle">1.007-1.054</td>
<td align="center" valign="middle">0.010</td>
</tr>
<tr>
<td align="left" valign="middle">CVD, yes vs. no</td>
<td align="center" valign="middle">1.103</td>
<td align="center" valign="middle">0.696-1.749</td>
<td align="center" valign="middle">0.677</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">T2DM, yes vs. no</td>
<td align="center" valign="middle">0.737</td>
<td align="center" valign="middle">0.440-1.233</td>
<td align="center" valign="middle">0.245</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">WBC, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">1.002</td>
<td align="center" valign="middle">0.976-1.028</td>
<td align="center" valign="middle">0.896</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">PLT, 10<sup>9</sup>/l</td>
<td align="center" valign="middle">0.997</td>
<td align="center" valign="middle">0.996-0.999</td>
<td align="center" valign="middle">0.008</td>
<td align="center" valign="middle">1.000</td>
<td align="center" valign="middle">0.997-1.002</td>
<td align="center" valign="middle">0.701</td>
</tr>
<tr>
<td align="left" valign="middle">CRP, mg/l</td>
<td align="center" valign="middle">1.003</td>
<td align="center" valign="middle">0.999-1.007</td>
<td align="center" valign="middle">0.129</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">PCT, ng/ml</td>
<td align="center" valign="middle">0.999</td>
<td align="center" valign="middle">0.992-1.006</td>
<td align="center" valign="middle">0.757</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">PT, sec</td>
<td align="center" valign="middle">0.999</td>
<td align="center" valign="middle">0.942-1.059</td>
<td align="center" valign="middle">0.965</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">FIB, g/l</td>
<td align="center" valign="middle">1.075</td>
<td align="center" valign="middle">0.956-1.210</td>
<td align="center" valign="middle">0.228</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">ALT, U/l</td>
<td align="center" valign="middle">1.001</td>
<td align="center" valign="middle">0.999-1.003</td>
<td align="center" valign="middle">0.179</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">ALB, g/l</td>
<td align="center" valign="middle">1.017</td>
<td align="center" valign="middle">0.978-1.057</td>
<td align="center" valign="middle">0.408</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">BUN, mmol/l</td>
<td align="center" valign="middle">0.985</td>
<td align="center" valign="middle">0.959-1.012</td>
<td align="center" valign="middle">0.283</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">SOFA score</td>
<td align="center" valign="middle">1.175</td>
<td align="center" valign="middle">1.104-1.251</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td align="center" valign="middle">1.177</td>
<td align="center" valign="middle">1.095-1.265</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">PITT</td>
<td align="center" valign="middle">1.037</td>
<td align="center" valign="middle">0.960-1.120</td>
<td align="center" valign="middle">0.362</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>ARDS, acute respiratory distress syndrome; CVD, cardiovascular disease; T2DM, type 2 diabetes; WBC, white blood cells; PLT, platelets; CRP, C-reactive protein; PCT, procalcitonin; PT, prothrombin time; FIB, fibrinogen; ALT, alanine aminotransferase; ALB, albumin; BUN, blood urea nitrogen; SOFA, Sequential Organ Failure Assessment; PITT, Pitt bacteremia score.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
